Ruchi Chawla

6PUBLICATIONS
7CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2026
Breaking barriers: nanosystems to overcome solubility and permeability challenges of second-generation tyrosine kinase inhibitors.

|Feb 28, 2025
Crafting a Molecular Trojan Horse: Sialic Acid-Modified PLGA Nanoparticles for Targeted Lung Cancer Therapy.

Krishan Kumar, Manjit Saini, Varsha Rani

|Sep 27, 2024
Epigallocatechin-3-gallate Synergistically Inhibits the Proliferation of Lung Cancer Cells with Gemcitabine by Induction of Apoptosis Mediated by ROS Generation.

Mohini Mishra, Kirti Wasnik, Aditya Sharma

|Jul 31, 2024
Evaluation of Gemcitabine and Epigallocatechin-3-Gallate Loaded Solid Lipid Nanoparticles on Benzopyrene Induced Lung Cancer Model Via Intranasal Route: Improved Pharmacokinetics and Safety Profile.

Mohini Mishra, Rinki Verma, Aditya Sharma

|Dec 19, 2023
In Vivo Cancer Microenvironment Responsive Glycan Receptor-Targeted Nanoparticles for Gemcitabine Delivery to Benzo[a]pyrene-Induced Lung Cancer Model.

Krishan Kumar, Rinki Verma, Manjit

|Oct 06, 2022
Design, fabrication, optimization and characterization of memantine-loaded biodegradable PLGA nanoscaffolds for treatment of Alzheimer's disease.

Varsha Rani, Ruchi Chawla

Pageof 1

Frequent Collaborators

2 joint publications

Brahmeshwar Mishra

1 joint publications

Kirti Wasnik

1 joint publications

Pradip Paik

1 joint publications

Manjit Saini